What we offerHealthcare is changing. Ethical pharma companies are facing pricing cut-backs in public healthcare spending and growing R&D costs. Physicians and patients increasingly turn to a more holistic view of healthcare, focusing more on prevention, and perceived mild to moderate therapies.
At konVet, we actively accompany these changes and support our clients in doing so. Our clients and partners work with us due to our market knowledge, comprehensive industry network, as well as our flexibility, speed and creativity in finding new solutions:
- We help researchers with promising and innovative solutions to bring their products to market, e.g. by finding investors to finance next phase development, or by identifying suitable drug industry partners.
- Together with our global expert network, we provide specialized consulting and management services for healthcare. We provide strategy support from market entry to exit, assist in creating a suitable management team from our network, and provide interim management for early stage companies.
- We identify M&A opportunities in small to mid-sized healthcare, and support companies in identifying suitable acquisition targets or potential buyers.
We can provide full-service solutions through our co-operation with the M&A specialists of a leading German bank.